Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Shares Outstanding (Diluted Average): 2009-2025

Historic Shares Outstanding (Diluted Average) for Madrigal Pharmaceuticals (MDGL) over the last 7 years, with Sep 2025 value amounting to $22.5 million.

  • Madrigal Pharmaceuticals' Shares Outstanding (Diluted Average) rose 3.39% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.5 million, marking a year-over-year increase of 3.39%. This contributed to the annual value of $21.3 million for FY2024, which is 13.83% up from last year.
  • Madrigal Pharmaceuticals' Shares Outstanding (Diluted Average) amounted to $22.5 million in Q3 2025, which was up 1.24% from $22.2 million recorded in Q2 2025.
  • Over the past 5 years, Madrigal Pharmaceuticals' Shares Outstanding (Diluted Average) peaked at $22.5 million during Q3 2025, and registered a low of $15.8 million during Q1 2021.
  • Over the past 3 years, Madrigal Pharmaceuticals' median Shares Outstanding (Diluted Average) value was $21.3 million (recorded in 2024), while the average stood at $20.4 million.
  • Data for Madrigal Pharmaceuticals' Shares Outstanding (Diluted Average) shows a peak YoY grew of 17.70% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Madrigal Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $16.5 million in 2021, then grew by 3.64% to $17.1 million in 2022, then climbed by 9.05% to $18.7 million in 2023, then grew by 13.83% to $21.3 million in 2024, then grew by 3.39% to $22.5 million in 2025.
  • Its last three reported values are $22.5 million in Q3 2025, $22.2 million for Q2 2025, and $22.1 million during Q1 2025.